FM
FOLD

Forward Management’s Amicus Therapeutics FOLD Stock Holding History

Forward Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-427,222
Closed -$4.52M – 279
2015
Q2 		$4.52M Sell
427,222
-209,658
-33% -$2.52M 0.28% 57
2015
Q1 		$6.05M Buy
+636,880
New +$5.61M 0.36% 51

Other funds holding FOLD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Forward Management's FOLD Position: Q3 2015 in Review

Forward Management sold out of Amicus Therapeutics (FOLD) in Q3 2015, closing a stake of 427,222 shares — an estimated $4.52M sold.

Forward Management first reported a position in FOLD in Q1 2015 and held it in 2 quarters. The position peaked at $6.05M in Q1 2015. 147 funds tracked by Wall St. Rank hold FOLD as of Q3 2015.

  • Forward Management reported no remaining Amicus Therapeutics position as of Q3 2015 after selling out during the quarter.
  • Forward Management sold 427,222 Amicus Therapeutics shares in Q3 2015, an estimated $4.52M.
  • Forward Management first reported a position in Amicus Therapeutics in Q1 2015 and held it in 2 quarters.
  • Forward Management's Amicus Therapeutics position peaked at $6.05M in Q1 2015.
  • 147 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q3 2015.

Based on Forward Management's 13F filing for Q3 2015, filed 9 Nov 2015.